fda warning bpc 157 not approved safety concerns panel backs compounded BPC-157, KPV peptides in win for RFK Jr Stuffy nose? Reach for phenylephrine!
Stuffy nose? Reach for phenylephrine! Well, not anymore. Last week, the FDA announced it is proposing to remove oral phenylephrine as an active ingredient that can be used in OTC drug products WATCH: FDA advisory panel narrowly backs use of several peptides favored by RFK Jr. The future of peptides in the US is about to become clearer. Here's what you should know CNN The Food and Drug Administration's committee on compounded drugs broke with agency scientists and voted in favor of adding peptides to the list of substances compounding pharmacies can make. Follow the link FDA's Overreach on Compounded Peptides FDA panel votes to loosen restrictions for controversial peptides BBC News
Pay in 4 interest-free payments of $6.11 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3



